ParaVax

Industry: Swine flu vaccine

ParaVax is developing a more effective vaccine for the swine flu virus. While three approved vaccines are on the market for swine flu, none is without issues.
 
ParaVax’s vaccine is based on PIV5, or canine parainfluenza virus (CPI). CPI is a non-segmented, negative-strand, RNA virus (NNSV) and has been deemed safe and stable as a vaccine vector.
 
The inventor of the platform technology, Dr. Biao He, has been working with PIV5 for around two decades. 

Back to companies

191 Peachtree Street, NE, Suite 849  |  Atlanta, Georgia 30303  |  404.332.9770  |  Directions  |  Privacy  |  GRA Venture Fund, LLC
Copyright © Georgia Research Alliance  |  All Rights Reserved